Press Release

The regulatory body approved AbbVie's glecaprevir/pibrentasvir (Maviret) for the treatment of acute hepatitis C virus infection in adults and children aged 3 years and older, making it the first and only therapy in the European Union approved for both acute and chronic HCV infection.

Two new complementary initiatives from CIDRAP’s Vaccine Integrity Project and The Evidence Collective aim to evaluate and improve US vaccine policymaking, governance, and public trust amid ongoing changes to the nation's immunization infrastructure.

Contagion® is partnering with PER® to provide CME to support clinicians during the global coronavirus pandemic.

Introducing the HCPLive Network, a collaborative system of specialty publications headlined by HCPLive®, Contagion®, NeurologyLive®, and Rare Disease Report®.

MAD-ID® is a nonprofit organization that offers a wealth of educational opportunities in the areas of infectious diseases prevention, management, and antimicrobial stewardship.

The top five affected states are Kentucky, West Virginia, Ohio, Florida, and Indiana.

Dr. Simon Murray says, “it’s time for the states to reconsider religious exemptions against the measles vaccination” and “measles cases are reaching new highs, but the majority of Americans’ risk remain low.”

The expert “Peer Exchange” panel focuses on specific information and educational needs of health care professionals involved in diagnosis and treatment of the HIV virus

Traffic to Contagion®'s digital platform nearly doubled year-over-year from 2017 to 2018.

Dr. Jason Gallagher discusses the responsibility of medical professionals to educate the community.

Affected states include Tennessee, West Virginia, Indiana, Michigan, Kentucky, Utah and California.

Specialists discuss causes and frontline prevention strategies in the infectious disease space.

Panel of experts discusses ongoing challenges and possible treatments for multidrug-resistant bacterial infections.

The outbreak has been linked to kratom, an opioid substitute.

Michael J. Hennessy Associates Inc.’s (MJH) premiere infectious disease publication, Contagion®, marks its second anniversary this month amid celebrations of its highest readership traffic to date.

William Schaffner, MD, explains what we can expect for the 2017-2018 flu season and how clinicians can ensure their patients get vaccinated.

In the USA: Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released in 2015 by the Centers for Disease Control and Prevention.

Many US Governors have signed a state proclamation proclaiming November 2017 as Clostridium difficile Infection Awareness Month,

The American Academy of HIV Medicine (AAHIVM) has partnered with the All of Us Research Program, part of the National Institutes of Health, to join in efforts to raise awareness about the program.

Dr. Gallagher to lead comprehensive infectious disease publication.

Contagion® and MD Magazine® together announce that they have expanded their Strategic Alliance Partnership (SAP) program with Jackson Health System.

The collaboration is part of Contagion®’s and MD Magazine®’s Strategic Alliance Partnership Program.

This year, our goal is to obtain proclamations in all 50 states.

Contagion® has unveiled its first Peer Exchange, a lively conversation between medical experts that provides opinions and perspectives on the controversy surrounding Lyme disease.

Contagion® and MD Magazine together announce that they have expanded their Strategic Alliance Partnership program with Ochsner Health System.

Through this partnership, readers can expect unprecedented content, such as research developments, articles, and interviews that can help physicians better serve their patients.

In recognition of Lyme disease awareness month, Contagion® interviewed Pat Smith, president of Lyme Disease Association, Inc, to better understand current issues surrounding the diagnosis and treatment of Lyme disease.

MD Magazine® and Contagion® partner with the C Diff Foundation.